Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid
Objective. Healthcare utilization and costs associated with systemic lupus erythematosus (SLE) in a US Medicaid population were examined. Methods. Patients ≥ 18 years old with SLE diagnosis (ICD-9-CM 710.0x) were extracted from a large Medicaid database 2002–2009. Index date was date of the first SL...
Gespeichert in:
| Veröffentlicht in: | BioMed research international 2013-01, Vol.2013 (2013), p.1-8 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 8 |
|---|---|
| container_issue | 2013 |
| container_start_page | 1 |
| container_title | BioMed research international |
| container_volume | 2013 |
| creator | O'Sullivan, Donna Bechtel, Benno Johnson, Barbara H. Song, Xue Kan, Hong J. Molta, Charles T. |
| description | Objective. Healthcare utilization and costs associated with systemic lupus erythematosus (SLE) in a US Medicaid population were examined. Methods. Patients ≥ 18 years old with SLE diagnosis (ICD-9-CM 710.0x) were extracted from a large Medicaid database 2002–2009. Index date was date of the first SLE diagnosis. Patients with and without SLE were matched. All patients had a variable length of followup with a minimum of 12 months. Annualized healthcare utilization and costs associated with SLE and costs of SLE flares were assessed during the followup period. Multivariate regressions were conducted to estimate incremental healthcare utilization and costs associated with SLE. Results. A total of 14,777 SLE patients met the study criteria, and 14,262 were matched to non-SLE patients. SLE patients had significantly higher healthcare utilization per year than their matched controls. The estimated incremental annual cost associated with SLE was $10,984, with the highest increase in inpatient costs (P |
| doi_str_mv | 10.1155/2013/808391 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3591216</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1317404306</sourcerecordid><originalsourceid>FETCH-LOGICAL-c533t-810f4b7181a73990b88428783864670efa54899b96f44afe95088ac4d094241e3</originalsourceid><addsrcrecordid>eNqNkcFrFDEUh4MottSevMuAF1HW5uW9ySQXoSzVCisetOeQncm4KTOTNcko619vlq1L9WJzSUI-fu_lfYw9B_4WoK4vBAe8UFyhhkfsVCDQQgLB4-MZ8YSdp3TLy1IguZZP2YlAUgRSnLLVtbND3rQ2uuom-8H_stmHqbJTVy1DyqkKffVll7IbfVut5u2cqqu4yxs32hxSufmp-uQ631rfPWNPejskd363n7Gb91dfl9eL1ecPH5eXq0VbI-aFAt7TugEFtkGt-VopEqpRqCTJhrve1qS0XmvZE9ne6ZorZVvquCZB4PCMvTvkbuf16LrWTTnawWyjH23cmWC9-ftl8hvzLfwwWGsQIEvAq7uAGL7PLmUz-tS6YbCTC3MyQJJqXosG_4-ibEq3RM0DUGiIE_J9Ay__QW_DHKcyNANCCSEVIRXqzYFqY0gpuv74ReBmr9_s9ZuD_kK_uD-VI_tHdgFeH4CNnzr70z8srYgule09GIsHxN_S2b4I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1282268434</pqid></control><display><type>article</type><title>Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>O'Sullivan, Donna ; Bechtel, Benno ; Johnson, Barbara H. ; Song, Xue ; Kan, Hong J. ; Molta, Charles T.</creator><contributor>Ranganath, Veena K.</contributor><creatorcontrib>O'Sullivan, Donna ; Bechtel, Benno ; Johnson, Barbara H. ; Song, Xue ; Kan, Hong J. ; Molta, Charles T. ; Ranganath, Veena K.</creatorcontrib><description>Objective. Healthcare utilization and costs associated with systemic lupus erythematosus (SLE) in a US Medicaid population were examined. Methods. Patients ≥ 18 years old with SLE diagnosis (ICD-9-CM 710.0x) were extracted from a large Medicaid database 2002–2009. Index date was date of the first SLE diagnosis. Patients with and without SLE were matched. All patients had a variable length of followup with a minimum of 12 months. Annualized healthcare utilization and costs associated with SLE and costs of SLE flares were assessed during the followup period. Multivariate regressions were conducted to estimate incremental healthcare utilization and costs associated with SLE. Results. A total of 14,777 SLE patients met the study criteria, and 14,262 were matched to non-SLE patients. SLE patients had significantly higher healthcare utilization per year than their matched controls. The estimated incremental annual cost associated with SLE was $10,984, with the highest increase in inpatient costs (P<0.001). Cost per flare was $11,716 for severe flares, $562 for moderate flares, and $129 for mild flares. Annual total costs for patients with severe flares were $49,754. Conclusions. SLE patients had significantly higher healthcare resource utilization and costs than non-SLE patients. Patients with severe flares had the highest costs.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2013/808391</identifier><identifier>PMID: 23484162</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adult ; Aged ; Comorbidity ; Costs and Cost Analysis ; Databases, Factual ; Female ; Follow-Up Studies ; Health care expenditures ; Humans ; Lupus ; Lupus Erythematosus, Systemic - drug therapy ; Lupus Erythematosus, Systemic - economics ; Lupus Erythematosus, Systemic - epidemiology ; Male ; Medicaid - economics ; Middle Aged ; Retrospective Studies ; Steroids ; Time Factors ; United States - epidemiology</subject><ispartof>BioMed research international, 2013-01, Vol.2013 (2013), p.1-8</ispartof><rights>Copyright © 2013 Hong J. Kan et al.</rights><rights>Copyright © 2013 Hong J. Kan et al. Hong J. Kan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Hong J. Kan et al. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c533t-810f4b7181a73990b88428783864670efa54899b96f44afe95088ac4d094241e3</citedby><cites>FETCH-LOGICAL-c533t-810f4b7181a73990b88428783864670efa54899b96f44afe95088ac4d094241e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591216/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591216/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23484162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ranganath, Veena K.</contributor><creatorcontrib>O'Sullivan, Donna</creatorcontrib><creatorcontrib>Bechtel, Benno</creatorcontrib><creatorcontrib>Johnson, Barbara H.</creatorcontrib><creatorcontrib>Song, Xue</creatorcontrib><creatorcontrib>Kan, Hong J.</creatorcontrib><creatorcontrib>Molta, Charles T.</creatorcontrib><title>Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Objective. Healthcare utilization and costs associated with systemic lupus erythematosus (SLE) in a US Medicaid population were examined. Methods. Patients ≥ 18 years old with SLE diagnosis (ICD-9-CM 710.0x) were extracted from a large Medicaid database 2002–2009. Index date was date of the first SLE diagnosis. Patients with and without SLE were matched. All patients had a variable length of followup with a minimum of 12 months. Annualized healthcare utilization and costs associated with SLE and costs of SLE flares were assessed during the followup period. Multivariate regressions were conducted to estimate incremental healthcare utilization and costs associated with SLE. Results. A total of 14,777 SLE patients met the study criteria, and 14,262 were matched to non-SLE patients. SLE patients had significantly higher healthcare utilization per year than their matched controls. The estimated incremental annual cost associated with SLE was $10,984, with the highest increase in inpatient costs (P<0.001). Cost per flare was $11,716 for severe flares, $562 for moderate flares, and $129 for mild flares. Annual total costs for patients with severe flares were $49,754. Conclusions. SLE patients had significantly higher healthcare resource utilization and costs than non-SLE patients. Patients with severe flares had the highest costs.</description><subject>Adult</subject><subject>Aged</subject><subject>Comorbidity</subject><subject>Costs and Cost Analysis</subject><subject>Databases, Factual</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Health care expenditures</subject><subject>Humans</subject><subject>Lupus</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Lupus Erythematosus, Systemic - economics</subject><subject>Lupus Erythematosus, Systemic - epidemiology</subject><subject>Male</subject><subject>Medicaid - economics</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Steroids</subject><subject>Time Factors</subject><subject>United States - epidemiology</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkcFrFDEUh4MottSevMuAF1HW5uW9ySQXoSzVCisetOeQncm4KTOTNcko619vlq1L9WJzSUI-fu_lfYw9B_4WoK4vBAe8UFyhhkfsVCDQQgLB4-MZ8YSdp3TLy1IguZZP2YlAUgRSnLLVtbND3rQ2uuom-8H_stmHqbJTVy1DyqkKffVll7IbfVut5u2cqqu4yxs32hxSufmp-uQ631rfPWNPejskd363n7Gb91dfl9eL1ecPH5eXq0VbI-aFAt7TugEFtkGt-VopEqpRqCTJhrve1qS0XmvZE9ne6ZorZVvquCZB4PCMvTvkbuf16LrWTTnawWyjH23cmWC9-ftl8hvzLfwwWGsQIEvAq7uAGL7PLmUz-tS6YbCTC3MyQJJqXosG_4-ibEq3RM0DUGiIE_J9Ay__QW_DHKcyNANCCSEVIRXqzYFqY0gpuv74ReBmr9_s9ZuD_kK_uD-VI_tHdgFeH4CNnzr70z8srYgule09GIsHxN_S2b4I</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>O'Sullivan, Donna</creator><creator>Bechtel, Benno</creator><creator>Johnson, Barbara H.</creator><creator>Song, Xue</creator><creator>Kan, Hong J.</creator><creator>Molta, Charles T.</creator><general>Hindawi Publishing Corporation</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130101</creationdate><title>Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid</title><author>O'Sullivan, Donna ; Bechtel, Benno ; Johnson, Barbara H. ; Song, Xue ; Kan, Hong J. ; Molta, Charles T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c533t-810f4b7181a73990b88428783864670efa54899b96f44afe95088ac4d094241e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Comorbidity</topic><topic>Costs and Cost Analysis</topic><topic>Databases, Factual</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Health care expenditures</topic><topic>Humans</topic><topic>Lupus</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Lupus Erythematosus, Systemic - economics</topic><topic>Lupus Erythematosus, Systemic - epidemiology</topic><topic>Male</topic><topic>Medicaid - economics</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Steroids</topic><topic>Time Factors</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Sullivan, Donna</creatorcontrib><creatorcontrib>Bechtel, Benno</creatorcontrib><creatorcontrib>Johnson, Barbara H.</creatorcontrib><creatorcontrib>Song, Xue</creatorcontrib><creatorcontrib>Kan, Hong J.</creatorcontrib><creatorcontrib>Molta, Charles T.</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Sullivan, Donna</au><au>Bechtel, Benno</au><au>Johnson, Barbara H.</au><au>Song, Xue</au><au>Kan, Hong J.</au><au>Molta, Charles T.</au><au>Ranganath, Veena K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>2013</volume><issue>2013</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Objective. Healthcare utilization and costs associated with systemic lupus erythematosus (SLE) in a US Medicaid population were examined. Methods. Patients ≥ 18 years old with SLE diagnosis (ICD-9-CM 710.0x) were extracted from a large Medicaid database 2002–2009. Index date was date of the first SLE diagnosis. Patients with and without SLE were matched. All patients had a variable length of followup with a minimum of 12 months. Annualized healthcare utilization and costs associated with SLE and costs of SLE flares were assessed during the followup period. Multivariate regressions were conducted to estimate incremental healthcare utilization and costs associated with SLE. Results. A total of 14,777 SLE patients met the study criteria, and 14,262 were matched to non-SLE patients. SLE patients had significantly higher healthcare utilization per year than their matched controls. The estimated incremental annual cost associated with SLE was $10,984, with the highest increase in inpatient costs (P<0.001). Cost per flare was $11,716 for severe flares, $562 for moderate flares, and $129 for mild flares. Annual total costs for patients with severe flares were $49,754. Conclusions. SLE patients had significantly higher healthcare resource utilization and costs than non-SLE patients. Patients with severe flares had the highest costs.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>23484162</pmid><doi>10.1155/2013/808391</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2314-6133 |
| ispartof | BioMed research international, 2013-01, Vol.2013 (2013), p.1-8 |
| issn | 2314-6133 2314-6141 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3591216 |
| source | MEDLINE; PubMed Central Open Access; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection |
| subjects | Adult Aged Comorbidity Costs and Cost Analysis Databases, Factual Female Follow-Up Studies Health care expenditures Humans Lupus Lupus Erythematosus, Systemic - drug therapy Lupus Erythematosus, Systemic - economics Lupus Erythematosus, Systemic - epidemiology Male Medicaid - economics Middle Aged Retrospective Studies Steroids Time Factors United States - epidemiology |
| title | Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A00%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Healthcare%20Utilization%20and%20Costs%20of%20Systemic%20Lupus%20Erythematosus%20in%20Medicaid&rft.jtitle=BioMed%20research%20international&rft.au=O'Sullivan,%20Donna&rft.date=2013-01-01&rft.volume=2013&rft.issue=2013&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2013/808391&rft_dat=%3Cproquest_pubme%3E1317404306%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1282268434&rft_id=info:pmid/23484162&rfr_iscdi=true |